US study suggests GLP-1 RA drugs are associated with small increase in ischemic optic neuropathy
A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy had a slightly higher risk of ischemic optic neuropathy (ION), a rare condition involving ...
Jul 13, 2026
0
5









